{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T23:11:19Z","timestamp":1757545879415},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,5,4]],"date-time":"2007-05-04T00:00:00Z","timestamp":1178236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,5,4]],"date-time":"2007-05-04T00:00:00Z","timestamp":1178236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1038\/sj.cgt.7701039","type":"journal-article","created":{"date-parts":[[2007,5,7]],"date-time":"2007-05-07T09:28:57Z","timestamp":1178530137000},"page":"661-675","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-\u03b1 gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors"],"prefix":"10.1038","volume":"14","author":[{"given":"Z","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Sas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,5,4]]},"reference":[{"key":"BF7701039_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1006\/cimm.1997.1140","volume":"178","author":"GE Plautz","year":"1997","unstructured":"Plautz GE, Touhalisky JE, Shu S . Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells. Cell Immunol 1997; 178: 101\u2013107.","journal-title":"Cell Immunol"},{"key":"BF7701039_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1006\/cimm.1997.1124","volume":"178","author":"L Peng","year":"1997","unstructured":"Peng L, Shu S, Krauss JC . Treatment of subcutaneous tumor with adoptively transferred T cells. Cell Immunol 1997; 178: 24\u201332.","journal-title":"Cell Immunol"},{"key":"BF7701039_CR3","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.4049\/jimmunol.162.6.3574","volume":"162","author":"H Tanaka","year":"1999","unstructured":"Tanaka H, Yoshizawa H, Yamaguchi Y, Ito K, Kagamu H, Suzuki E et al. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells. J Immunol 1999; 162: 3574\u20133582.","journal-title":"J Immunol"},{"key":"BF7701039_CR4","first-page":"3077","volume":"61","author":"SC Eck","year":"2001","unstructured":"Eck SC, Turka LA . Adoptive transfer enables tumor rejection targeted against a self-antigen without the induction of autoimmunity. Cancer Res 2001; 61: 3077\u20133083.","journal-title":"Cancer Res"},{"key":"BF7701039_CR5","doi-asserted-by":"publisher","first-page":"916","DOI":"10.4049\/jimmunol.164.2.916","volume":"164","author":"MJ Dobrzanski","year":"2000","unstructured":"Dobrzanski MJ, Reome JB, Dutton RW . Type 1 and type 2 CD8+ effector T cell subpopulations promote long-term tumor immunity and protection to progressively growing tumor. J Immunol 2000; 164: 916\u2013925.","journal-title":"J Immunol"},{"key":"BF7701039_CR6","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/nm1001-1159","volume":"7","author":"C Becker","year":"2001","unstructured":"Becker C, Pohla H, Frankenberger B, Schuler T, Assenmacher M, Schendel DJ et al. Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay. Nat Med 2001; 7: 1159\u20131162.","journal-title":"Nat Med"},{"key":"BF7701039_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ijc.2910550118","volume":"55","author":"GA Gastl","year":"1993","unstructured":"Gastl GA, Abrams JS, Nanus DM, Oosterkamp R, Silver J, Liu F et al. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer 1993; 55: 96\u2013101.","journal-title":"Int J Cancer"},{"key":"BF7701039_CR8","first-page":"18","volume":"145","author":"DR Smith","year":"1994","unstructured":"Smith DR, Kunkel SL, Burdick MD, Wilke CA, Orringer MB, Whyte RI et al. Production of interleukin-10 by human bronchogenic carcinoma. Am J Pathol 1994; 145: 18\u201325.","journal-title":"Am J Pathol"},{"key":"BF7701039_CR9","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1182\/blood.V81.11.2964.2964","volume":"81","author":"K Taga","year":"1993","unstructured":"Taga K, Mostowski H, Tosato G . Human interleukin-10 can directly inhibit T-cell growth. Blood 1993; 81: 2964\u20132971.","journal-title":"Blood"},{"key":"BF7701039_CR10","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1182\/blood.V99.7.2468","volume":"99","author":"K Steinbrink","year":"2002","unstructured":"Steinbrink K, Graulich E, Kubsch S, Knop J, Enk AH . CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 2002; 99: 2468\u20132476.","journal-title":"Blood"},{"key":"BF7701039_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1084\/jem.184.1.19","volume":"184","author":"H Groux","year":"1996","unstructured":"Groux H, Bigler M, de Vries JE, Roncarolo MG . Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 1996; 184: 19\u201329.","journal-title":"J Exp Med"},{"key":"BF7701039_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1089\/10430340050015581","volume":"11","author":"CL Hsieh","year":"2000","unstructured":"Hsieh CL, Chen DS, Hwang LH . Tumor-induced immunosuppression: a barrier to immunotherapy of large tumors by cytokine-secreting tumor vaccine. Hum Gene Ther 2000; 11: 681\u2013692.","journal-title":"Hum Gene Ther"},{"key":"BF7701039_CR13","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.4049\/jimmunol.166.6.3789","volume":"166","author":"M Hara","year":"2001","unstructured":"Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, Bushell AR et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166: 3789\u20133796.","journal-title":"J Immunol"},{"key":"BF7701039_CR14","first-page":"2150","volume":"63","author":"AS Yang","year":"2003","unstructured":"Yang AS, Lattime EC . Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses. Cancer Res 2003; 63: 2150\u20132157.","journal-title":"Cancer Res"},{"key":"BF7701039_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/sj.cgt.7700418","volume":"9","author":"K Kawamura","year":"2002","unstructured":"Kawamura K, Bahar R, Natsume W, Sakiyama S, Tagawa M . Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors. Cancer Gene Ther 2002; 9: 109\u2013115.","journal-title":"Cancer Gene Ther"},{"key":"BF7701039_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1046\/j.1365-2567.2002.01363.x","volume":"105","author":"ML Garcia-Hernandez","year":"2002","unstructured":"Garcia-Hernandez ML, Hernandez-Pando R, Gariglio P, Berumen J . Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation. Immunology 2002; 105: 231\u2013243.","journal-title":"Immunology"},{"key":"BF7701039_CR17","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/00000658-200004000-00015","volume":"231","author":"GY Chau","year":"2000","unstructured":"Chau GY, Wu CW, Lui WY, Chang TJ, Kao HL, Wu LH et al. Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann Surg 2000; 231: 552\u2013558.","journal-title":"Ann Surg"},{"key":"BF7701039_CR18","first-page":"357","volume":"7","author":"F De Vita","year":"2000","unstructured":"De Vita F, Orditura M, Galizia G, Romano C, Lieto E, Iodice P et al. Serum interleukin-10 is an independent prognostic factor in advanced solid tumors. Oncol Rep 2000; 7: 357\u2013361.","journal-title":"Oncol Rep"},{"key":"BF7701039_CR19","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.4049\/jimmunol.144.12.4555","volume":"144","author":"E Robinet","year":"1990","unstructured":"Robinet E, Branellec D, Termijtelen AM, Blay JY, Gay F, Chouaib S et al. Evidence for tumor necrosis factor-alpha involvement in the optimal induction of class I allospecific cytotoxic T cells. J Immunol 1990; 144: 4555\u20134561.","journal-title":"J Immunol"},{"key":"BF7701039_CR20","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.4049\/jimmunol.160.11.5221","volume":"160","author":"M Lahn","year":"1998","unstructured":"Lahn M, Kalataradi H, Mittelstadt P, Pflum E, Vollmer M, Cady C et al. Early preferential stimulation of gamma delta T cells by TNF-alpha. J Immunol 1998; 160: 5221\u20135230.","journal-title":"J Immunol"},{"key":"BF7701039_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1046\/j.1365-2567.2003.01489.x","volume":"108","author":"W Zhang","year":"2003","unstructured":"Zhang W, Chen Z, Li F, Kamencic H, Juurlink B, Gordon JR et al. Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha. Immunology 2003; 108: 177\u2013188.","journal-title":"Immunology"},{"key":"BF7701039_CR22","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.4049\/jimmunol.165.7.3647","volume":"165","author":"LA Lyakh","year":"2000","unstructured":"Lyakh LA, Koski GK, Telford W, Gress RE, Cohen PA, Rice NR et al. Bacterial lipopolysaccharide, TNF-alpha, and calcium ionophore under serum-free conditions promote rapid dendritic cell-like differentiation in CD14+ monocytes through distinct pathways that activate NK-kappa B. J Immunol 2000; 165: 3647\u20133655.","journal-title":"J Immunol"},{"key":"BF7701039_CR23","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4049\/jimmunol.163.3.1133","volume":"163","author":"H Sepulveda","year":"1999","unstructured":"Sepulveda H, Cerwenka A, Morgan T, Dutton RW . CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation. J Immunol 1999; 163: 1133\u20131142.","journal-title":"J Immunol"},{"key":"BF7701039_CR24","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.4049\/jimmunol.165.11.6278","volume":"165","author":"C Brunner","year":"2000","unstructured":"Brunner C, Seiderer J, Schlamp A, Bidlingmaier M, Eigler A, Haimerl W et al. Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo. J Immunol 2000; 165: 6278\u20136286.","journal-title":"J Immunol"},{"key":"BF7701039_CR25","first-page":"4485","volume":"60","author":"P Brossart","year":"2000","unstructured":"Brossart P, Zobywalski A, Grunebach F, Behnke L, Stuhler G, Reichardt VL et al. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells. Cancer Res 2000; 60: 4485\u20134492.","journal-title":"Cancer Res"},{"key":"BF7701039_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/cbr.1999.14.49","volume":"14","author":"P Wright","year":"1999","unstructured":"Wright P, Braun R, Babiuk L, Littel-van den Hurk SD, Moyana T, Zheng C et al. Adenovirus-mediated TNF-alpha gene transfer induces significant tumor regression in mice. Cancer Biother Radiopharm 1999; 14: 49\u201357.","journal-title":"Cancer Biother Radiopharm"},{"key":"BF7701039_CR27","doi-asserted-by":"publisher","first-page":"7497","DOI":"10.4049\/jimmunol.174.12.7497","volume":"174","author":"J Xiang","year":"2005","unstructured":"Xiang J, Huang H, Liu Y . A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells. J Immunol 2005; 174: 7497\u20137505.","journal-title":"J Immunol"},{"key":"BF7701039_CR28","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.4049\/jimmunol.166.10.6099","volume":"166","author":"M Li","year":"2001","unstructured":"Li M, Davey GM, Sutherland RM, Kurts C, Lew AM, Hirst C et al. Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol 2001; 166: 6099\u20136103.","journal-title":"J Immunol"},{"key":"BF7701039_CR29","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","volume":"95","author":"TC He","year":"1998","unstructured":"He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509\u20132514.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF7701039_CR30","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1089\/1043034041361181","volume":"15","author":"Y Liu","year":"2004","unstructured":"Liu Y, Ye T, Sun D, Maynard J, Deisseroth A . Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma. Hum Gene Ther 2004; 15: 637\u2013647.","journal-title":"Hum Gene Ther"},{"key":"BF7701039_CR31","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/sj.gt.3302797","volume":"13","author":"T Chan","year":"2006","unstructured":"Chan T, Sami A, El-Gayed A, Guo X, Xiang J . HER-2\/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2\/neu-specific immune responses compared to DNA vaccination. Gene ther 2006; 13: 1391\u20131402.","journal-title":"Gene ther"},{"key":"BF7701039_CR32","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2144\/01312bm04","volume":"31","author":"M Zeng","year":"2001","unstructured":"Zeng M, Smith SK, Siegel F, Shi Z, Van Kampen KR, Elmets CA et al. AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination. Biotechniques 2001; 31: 260\u2013262.","journal-title":"Biotechniques"},{"key":"BF7701039_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0008-8749(02)00508-7","volume":"217","author":"H Huang","year":"2002","unstructured":"Huang H, Liu Y, Xiang J . Synergistic effect of adoptive T-cell therapy and intratumoral interferon gamma-inducible protein-10 transgene expression in treatment of established tumors. Cell Immunol 2002; 217: 12\u201322.","journal-title":"Cell Immunol"},{"key":"BF7701039_CR34","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/sj.cgt.7700498","volume":"9","author":"Z Chen","year":"2002","unstructured":"Chen Z, Huang H, Chang T, Carsen S, Saxena A, Marr R et al. Enhanced HER-2\/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2\/neu and alpha tumor necrosis factor. Cancer Gene Ther 2002; 9: 778\u2013786.","journal-title":"Cancer Gene Ther"},{"key":"BF7701039_CR35","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/jgm.387","volume":"5","author":"Y Liu","year":"2003","unstructured":"Liu Y, Huang H, Chen Z, Zong L, Xiang J . Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity. J Gene Med 2003; 5: 668\u2013680.","journal-title":"J Gene Med"},{"key":"BF7701039_CR36","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.4049\/jimmunol.177.5.2976","volume":"177","author":"D Xia","year":"2006","unstructured":"Xia D, Hao S, Xiang J . CD8+ cytotoxic T-APC stimulate central memory CD8+ T cell responses via acquired peptide-MHC class I complexes and CD80 costimulation and IL-2 secretion. J Immunol 2006; 177: 2976\u20132984.","journal-title":"J Immunol"},{"key":"BF7701039_CR37","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1172\/JCI25427","volume":"115","author":"DE Speiser","year":"2005","unstructured":"Speiser DE, Romero P . Toward improved immunocompetence of adoptively transferred CD8+ T cells. J Clin Invest 2005; 115: 1467\u20131469.","journal-title":"J Clin Invest"},{"key":"BF7701039_CR38","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.immuni.2005.03.005","volume":"22","author":"DJ Zammit","year":"2005","unstructured":"Zammit DJ, Cauley LS, Pham QM, Lefrancois L . Dendritic cells maximize the memory CD8 T cell response to infection. Immunity 2005; 22: 561\u2013570.","journal-title":"Immunity"},{"key":"BF7701039_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1006\/mthe.2000.0044","volume":"1","author":"MR Dyer","year":"2000","unstructured":"Dyer MR, Herrling PL . Progress and potential for gene-based medicines. Mol Ther 2000; 1: 213\u2013224.","journal-title":"Mol Ther"},{"key":"BF7701039_CR40","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1126\/science.299.5605.320","volume":"299","author":"E Marshall","year":"2003","unstructured":"Marshall E . Gene therapy. Second child in French trial is found to have leukemia. Science 2003; 299: 320.","journal-title":"Science"},{"key":"BF7701039_CR41","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"JM Bergelson","year":"1997","unstructured":"Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320\u20131323.","journal-title":"Science"},{"key":"BF7701039_CR42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","volume":"73","author":"TJ Wickham","year":"1993","unstructured":"Wickham TJ, Mathias P, Cheresh DA, Nemerow GR . Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993; 73: 309\u2013319.","journal-title":"Cell"},{"key":"BF7701039_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/viro.2000.0468","volume":"274","author":"GR Nemerow","year":"2000","unstructured":"Nemerow GR . Cell receptors involved in adenovirus entry. Virology 2000; 274: 1\u20134.","journal-title":"Virology"},{"key":"BF7701039_CR44","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1128\/jvi.69.4.2257-2263.1995","volume":"69","author":"S Huang","year":"1995","unstructured":"Huang S, Endo RI, Nemerow GR . Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol 1995; 69: 2257\u20132263.","journal-title":"J Virol"},{"key":"BF7701039_CR45","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1128\/jvi.70.7.4502-4508.1996","volume":"70","author":"S Huang","year":"1996","unstructured":"Huang S, Kamata T, Takada Y, Ruggeri ZM, Nemerow GR . Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J Virol 1996; 70: 4502\u20134508.","journal-title":"J Virol"},{"key":"BF7701039_CR46","first-page":"7913","volume":"61","author":"N Okada","year":"2001","unstructured":"Okada N, Saito T, Masunaga Y, Tsukada Y, Nakagama S, Mizuguchi H et al. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells. Cancer Res 2001; 61: 7913\u20137919.","journal-title":"Cancer Res"},{"key":"BF7701039_CR47","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/sj.cgt.7700586","volume":"10","author":"N Okada","year":"2003","unstructured":"Okada N, Masunaga Y, Okada Y, Iiyama S, Mori N, Tsuda T et al. Gene transduction efficiency and maturation status in mouse bone marrow-derived dendritic cells infected with conventional or RGD fiber-mutant adenovirus vectors. Cancer Gene Ther 2003; 10: 421\u2013431.","journal-title":"Cancer Gene Ther"},{"key":"BF7701039_CR48","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1126\/science.7518614","volume":"265","author":"D Kagi","year":"1994","unstructured":"Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265: 528\u2013530.","journal-title":"Science"},{"key":"BF7701039_CR49","first-page":"2043","volume":"62","author":"H Huang","year":"2002","unstructured":"Huang H, Li F, Gordon JR, Xiang J . Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression. Cancer Res 2002; 62: 2043\u20132051.","journal-title":"Cancer Res"},{"key":"BF7701039_CR50","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/sj.gt.3302486","volume":"12","author":"H Huang","year":"2005","unstructured":"Huang H, Bi XG, Yuan JY, Xu SL, Guo XL, Xiang J . Combined CD4+ Th1 effect and lymphotactin transgene expression enhance CD8+ Tc1 tumor localization and therapy. Gene Ther 2005; 12: 999\u20131010.","journal-title":"Gene Ther"},{"key":"BF7701039_CR51","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.4049\/jimmunol.163.8.4462","volume":"163","author":"H Winter","year":"1999","unstructured":"Winter H, Hu HM, Urba WJ, Fox BA . Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L\/CD95L). J Immunol 1999; 163: 4462\u20134472.","journal-title":"J Immunol"},{"key":"BF7701039_CR52","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.4049\/jimmunol.170.4.2004","volume":"170","author":"CH Poehlein","year":"2003","unstructured":"Poehlein CH, Hu HM, Yamada J, Assmann I, Alvord WG, Urba WJ et al. TNF plays an essential role in tumor regression after adoptive transfer of perforin\/IFN-gamma double knockout effector T cells. J Immunol 2003; 170: 2004\u20132013.","journal-title":"J Immunol"},{"key":"BF7701039_CR53","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.4049\/jimmunol.177.5.3004","volume":"177","author":"JA Hollenbaugh","year":"2006","unstructured":"Hollenbaugh JA, Dutton RW . IFN-gamma regulates donor CD8 T cell expansion, migration, and leads to apoptosis of cells of a solid tumor. J Immunol 2006; 177: 3004\u20133011.","journal-title":"J Immunol"},{"key":"BF7701039_CR54","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/eji.200526175","volume":"36","author":"U Blohm","year":"2006","unstructured":"Blohm U, Potthoff D, van der Kogel AJ, Pircher H . Solid tumors \u2018melt\u2019 from the inside after successful CD8 T cell attack. Eur J Immunol 2006; 36: 468\u2013477.","journal-title":"Eur J Immunol"},{"key":"BF7701039_CR55","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.4049\/jimmunol.164.7.3645","volume":"164","author":"A Prevost-Blondel","year":"2000","unstructured":"Prevost-Blondel A, Roth E, Rosenthal FM, Pircher H . Crucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo. J Immunol 2000; 164: 3645\u20133651.","journal-title":"J Immunol"},{"key":"BF7701039_CR56","first-page":"1333","volume":"5","author":"C Sarraf","year":"1994","unstructured":"Sarraf C . Tumor necrosis factor and cell death in tumors. Int J Oncol 1994; 5: 1333\u20131339.","journal-title":"Int J Oncol"},{"key":"BF7701039_CR57","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1146\/annurev.med.45.1.491","volume":"45","author":"KJ Tracey","year":"1994","unstructured":"Tracey KJ, Cerami A . Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994; 45: 491\u2013503.","journal-title":"Annu Rev Med"},{"key":"BF7701039_CR58","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/nm0498-408","volume":"4","author":"C Ruegg","year":"1998","unstructured":"Ruegg C, Yilmaz A, Bieler G, Bamat J, Chaubert P, Lejeune FJ et al. Evidence for the involvement of endothelial cell integrin alpha V beta 3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. Nat Med 1998; 4: 408\u2013414.","journal-title":"Nat Med"},{"key":"BF7701039_CR59","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1259\/0007-1285-66-783-181","volume":"66","author":"J Denekamp","year":"1993","unstructured":"Denekamp J . Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br J Radiol 1993; 66: 181\u2013196.","journal-title":"Br J Radiol"},{"key":"BF7701039_CR60","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","volume":"108","author":"X Valencia","year":"2006","unstructured":"Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM, Lipsky PE . TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 2006; 108: 253\u2013261.","journal-title":"Blood"},{"key":"BF7701039_CR61","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","volume":"333","author":"EA Walter","year":"1995","unstructured":"Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995; 333: 1038\u20131044.","journal-title":"N Engl J Med"},{"key":"BF7701039_CR62","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/00002371-200107000-00012","volume":"24","author":"ME Dudley","year":"2001","unstructured":"Dudley ME, Wunderlich J, Nishimura MI, Yu D, Yang JC, Topalian SL et al. Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J Immunother 2001; 24: 363\u2013373.","journal-title":"J Immunother"},{"key":"BF7701039_CR63","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1126\/science.1062416","volume":"293","author":"J Sprent","year":"2001","unstructured":"Sprent J, Tough DF . T cell death and memory. Science 2001; 293: 245\u2013248.","journal-title":"Science"},{"key":"BF7701039_CR64","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.4049\/jimmunol.176.12.7385","volume":"176","author":"HG Zhang","year":"2006","unstructured":"Zhang HG, Liu C, Su K, Yu S, Zhang L, Zhang S et al. A membrane form of TNF-alpha presented by exosomes delays T cell activation-induced cell death. J Immunol 2006; 176: 7385\u20137393.","journal-title":"J Immunol"},{"key":"BF7701039_CR65","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.4049\/jimmunol.172.3.1380","volume":"172","author":"MJ Dobrzanski","year":"2004","unstructured":"Dobrzanski MJ, Reome JB, Hollenbaugh JA, Dutton RW . Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses. J Immunol 2004; 172: 1380\u20131390.","journal-title":"J Immunol"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/7701039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7701039","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7701039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T03:48:04Z","timestamp":1707882484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/7701039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,4]]},"references-count":65,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["BF7701039"],"URL":"https:\/\/doi.org\/10.1038\/sj.cgt.7701039","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,4]]},"assertion":[{"value":"2 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}